Arbutus Biopharma (0SGC.LSE) Q2 2025 Earnings

14MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.13
-0.11
-0.09
-0.07

Details

Expected EPS
-0.104
Actual EPS
-0.13
Surprise EPS
-0.03
Surprise Percent
+25%

Description

Arbutus Biopharma (0SGC.LSE) has reported earnings of -0.13 per share for Q2 2025.

0 Comments

Share your thoughts